Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Pacific Pharma, Inc., priced at $2.0414 per ML under NDC 82182045515. Its NADAC has been published 209 times since Nov 16, 2022.

FDA first approved this application on Oct 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

BRIMONIDINE TARTRATE, TIMOLOL MALEATE
$2.0414per ML

Strength

2; 5 mg/mL; mg/mL

NDC

82182045515

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

TOPICAL

Effective Date

10/21/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021398

FDA Approved

10/30/2007

TE Code

AB

On Market Since

10/21/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 209 times since Nov 16, 2022, and over the history we have for it it has declined 93.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0414 per ML
All-time high$30.7775 (Dec 14, 2022)
All-time low$1.8390 (Aug 19, 2026)
52-week high$6.2321
52-week low$1.8390
Median price$8.7045
Average price$9.8882
Largest weekly change+75.9% (Aug 21, 2024)
Weeks tracked209
Tracking sinceNov 16, 2022

Price History

1W

0.0%

1M

+3.5%

3M

+5.6%

6M

-14.3%

1Y

-70.3%

3Y

-88.1%

5Y

N/A

All

-93.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Pacific Pharma, Inc., is $2.0414 per ML (NDC 82182045515), effective Nov 11, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 93.1%. It has been tracked across 209 weekly CMS publications since Nov 16, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Nov 16, 2022, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.8390 (Aug 19, 2026) to a high of $30.7775 (Dec 14, 2022), with a median of $8.7045 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $1.9993 per ML — about 2% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 82182045515) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.